Cystic Fibrosis Home > Pertzye and Breastfeeding
It is unclear if Pertzye passes through breast milk. However, it can be dangerous for a woman to not receive treatment for a pancreatic enzyme deficiency, as it could cause malnutrition. In many cases, the benefits of using Pertzye while breastfeeding outweigh the potential risks to a nursing child. You can discuss this further with your doctor.
Pertzye® (pancrelipase) is a prescription medication approved for the treatment of exocrine pancreatic insufficiency, such as the type of deficiency that occurs with cystic fibrosis. It is unknown whether Pertzye passes through breast milk in humans.
Pertzye has not been studied in any breastfeeding humans or animals. Thus, it is unknown if it passes through breast milk.
Breastfeeding is a time of increased nutritional need for mothers, and it would not be a good time to leave a pancreatic digestive enzyme deficiency untreated due to the risk for malnutrition. In many (if not most) cases, the benefits of Pertyze for a breastfeeding woman will exceed the likely risks to the nursing child.
You should discuss breastfeeding and Pertzye use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.